Trials and registries - Long term clinical outcomes after BRS implantation

Session comprising selected EuroPCR 2019 Late-Breaking Trial submissions

Chairpersons: A. Al Nooryani, A. Seth
SHOW MORE

Summary

Consult this session to learn more about the latest trials and registries regarding the long term clinical outcomes after BRS implantation: GABI-R, ABSORB, PRAGUE-19, and more!

Presentations available when logged in:

  • German-Austrian register to evaluate the short- and long-term safety and therapy outcomes of the ABSORB everolimus-eluting BRS system in patient wi...
  • Final three-year outcomes of patients receiving everolimus-eluting BRS in real-world practice: the ABSORB UK registry
  • France ABSORB registry: three-year follow-up
  • BRS implantation in STEMI patients: five-year follow-up of PRAGUE-19 study
  • Comparison of ABSORB BRS with Xience everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes of the AIDA trial
  • The influence of implantation techniques (predilatation, sizing, post-dilatation) on lesion oriented outcomes in lesions treated with an ABSORB BRS...
  • MeRes-1 Extend: Two-year clinical and imaging outcome results with a thin-strut, sirolimus-eluting bioresorbable vascular scaffold in patients with...
  • Three-year clinical and two-year multimodality imaging results of thin-strut sirolimus-eluting BRS in patients with coronary artery disease